IL15 and breast carcinoma: On the other hand, a recent study carried out using the tumor tissues of 148 patients with primary breast cancer correlated the high levels of PD-L1 with low circulating values of vascular endothelial growth factor (VEGF), tumor necrosis factor-beta (TNF-β), and interleukin 15 (IL-15) [82].